Natural cervical ripening to delay pharmacological induction of labor
Official title: Natural Cervical Ripening to Prevent Pharmacological Induction of Labor - a Pilot Study.
Run by University of Zurich · NCT07587632 · Data updated 2026-11-12
This pilot study tests whether nipple stimulation and membrane sweeping can help some pregnant people go into labor on their own without needing drugs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 74 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Status | Recruiting |
| Started | April 10, 2026 |
| Main results expected | March 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07587632 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with singleton pregnancies and diet-controlled gestational diabetes, at or beyond 34 weeks, planning vaginal birth at University Hospital Zurich and planning IOL at 40 weeks.
✕Probably not a fit
Women with insulin-dependent diabetes, multiple gestations, fetal growth concerns, or those already in labor or scheduled for cesarean may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This investigator-initiated, single-center randomized controlled trial evaluates natural cervical ripening methods in women with diet-controlled gestational diabetes who are at 37–40 weeks and plan vaginal birth. Participants are assigned to receive membrane sweeping and/or breast massage with potential colostrum–related activities in an outpatient setting to see if spontaneous labor starts sooner. The study aims to measure time from 37 weeks to spontaneous labor, plus rates of spontaneous labor before planned induction, use of oxytocin or induction medications, duration of hospitalization, postpartum hemorrhage, mode of birth, and maternal/neonatal outcomes. Safety and feasibility of these nonpharmacological interventions are also assessed. Enrollment targets 74 eligible pregnant individuals can participate under German or English language instructions at the University Hospital Zurich.
Why it matters
Potential benefit: If successful, could reduce reliance on pharmacological induction and improve birth experience for some patients.
How similar studies have gone: Prior nonpharmacologic cervical ripening approaches have shown variable but promising results in promoting spontaneous labor in selected populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Singleton gestation * Non-insulin dependent, dietetically managed gestational diabetes * Greater than or equal to 34 weeks. * Planned vaginal birth at the University Hospital of Zurich * Planned IOL for 40 weeks of gestation. * Communication in German and/or English language possible. Exclusion Criteria: * Pregnant women with multiple gestation * Fetal macrosomia \>95th percentile * Intrauterine growth restriction \<3rd percentile * Already in labor (regular contractions or premature rupture of membranes (PROM) * Patients scheduled for IOL before 40 weeks * Insulin-dependent diabetes * Planned cesarean section * Planned birth in an external hospital * Inability to follow the procedures e.g. due to language problems, psychological disorders
Where it's running
-
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Verena Bossung, PD. Dr. med. — University of Zurich
- Study coordinator: Verena Bossung, PD Dr. med.
- Email: verena.bossung@usz.ch
- Phone: +44 43 253 28 47
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How the placenta affects maternal and fetal health
This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.
-
Gestational diabetes and health outcomes for mothers and babies
This project will follow pregnant women with gestational diabetes to see how the condition affects mothers and their babies during pregnancy, delivery, and early postpartum.
-
Pilot testing daily fermented poi to improve the maternal microbiome and lower gestational diabetes risk
This pilot will test whether eating one pound of fermented poi daily for four weeks can change the maternal microbiome and lower gestational diabetes risk for pregnant people in mid-pregnancy.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.